Health Care: Drugs

NewLink Genetics Corp (NLNK: NASDAQ)

$25.6 -0.1 | -0.39%
09/16/14 - 10:06 AM ET
Company Profile
Price and Volume
Recent Price 25.70
52 Week High 53.48
52 Week Low 16.00
Avg. Daily Vol. (Mil) 0.36
Beta (3 year) -0.37
Share Related Items
Mkt Cap (Mil) 717.26
Shares Out (Mil) 27.91
Float (Mil) 16.91
Dividend Information
Yield % 0.00
Annual Dividend 0.00
Payout Ratio 0.00
Financial Strength
Quick Ratio 20.20
Current Ratio 20.30
LT Debt/ Equity 0.01
Total Debt / Equity 0.02
Valuation Ratios
Price Earnings n.a.
Price/Sales 649.11
Price/Book 9.88
Price/Cash Flow -21.40
Per Share Data
Earnings -1.29
Sales 0.04
Book Value 2.60
Cash Flow -1.20
Business Summary
NewLink Genetics Corp., is a biopharmaceutical company. It focuses on discovering, developing and commercializing immunotherapeutic products to improve cancer treatment options for patients and physicians.
General Information
2503 South Loop Drive
Suite 5100
Ames, IA 50010
Industry : Drugs
Sector: Health Care
Employees: 104
CEO: Mr. Charles J. Link, Jr
Short Interest
Current Month (Mil) 5.52
Previous Month (Mil) 4.88
Short Interest Ratio (Days) 11.20
Management Effectiveness
Return on Equity n.a.
Return on Assets -40.80
Return on Investments -47.00
Gross Margin n.a.
EBIT Margin n.a.
Profit Margin 0.00

Portfolios with NLNK

Latest NLNK Headlines from TheStreet

More Financial News for NLNK

Press Releases for NLNK

See All Press Releases
brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter